Association Between Neuropathic Pain, Pregabalin Treatment, and Erectile Dysfunction

التفاصيل البيبلوغرافية
العنوان: Association Between Neuropathic Pain, Pregabalin Treatment, and Erectile Dysfunction
المؤلفون: Mansur Dağgülli, Serda Em, Yaşar Bozkurt, İsa Özbey, Cüneyt Göçmez, Mehtap Bozkurt, Mehmet Yıldız, Murat Atar, Haluk Söylemez
المصدر: The Journal of Sexual Medicine. 11:1816-1822
بيانات النشر: Oxford University Press (OUP), 2014.
سنة النشر: 2014
مصطلحات موضوعية: Adult, Male, Libido, Urology, Endocrinology, Diabetes and Metabolism, Pregabalin, Endocrinology, Erectile Dysfunction, Surveys and Questionnaires, medicine, Humans, Psychogenic disease, gamma-Aminobutyric Acid, Depression (differential diagnoses), Analgesics, Depression, business.industry, Coitus, medicine.disease, Psychiatry and Mental health, Sexual desire, Treatment Outcome, Erectile dysfunction, Reproductive Medicine, Patient Satisfaction, Anesthesia, Neuropathic pain, Neuralgia, Anxiety, medicine.symptom, business, Body mass index, medicine.drug
الوصف: Introduction The pathophysiology of erectile dysfunction (ED) may be vasculogenic, hormonal, anatomical, neurogenic, drug‐induced and/or psychogenic in origin. Neuropathic pain (NP) may facilitate ED, because it is frequently associated with anxiety, depression, and its drug, pregabalin, may also contribute ED. Aim The objective of this study was to determine whether pregabalin treatment for patients with neuropathic pain promotes erectile dysfunction. Methods The study sample consisted of a total of 102 male subjects that were subdivided into three groups. Group 1 patients (n = 31) had a pre‐existing diagnosis of NP and was treated with 300 mg/day of pregabalin for at least 3 months. Group 2 patients (n = 34) were diagnosed with NP for at least 3 months; however, neither were they treated with pregabalin nor did they received physical therapy throughout the study. Lastly, healthy age‐matched control subjects comprised group 3 (n = 37). Main Outcome Measures Patients in all groups completed the International Index for Erectile Function (IIEF) questionnaire. Results Mean age and mean body mass index did not differ significantly between each of the three groups. The cause of NP and the mean duration of having a diagnosis of NP did not differ significantly in groups 1 and 2. However, IIEF scores were significantly lower for group 1 when compared to group 2 in terms of erectile function, orgasmic function, overall satisfaction and total score. Yet groups 1 and 2 did not diverge significantly in the intercourse satisfaction and sexual desire scores. Overall IIEF scores for group 3 were significantly higher than those of group 2 except for mean erectile function scores. Conclusion Taking pregabalin for the treatment of neuropathic pain poses an increased risk for developing ED in male patients. Thus, clinicians prescribing pregabalin to patients diagnosed with neuropathic pain should assess for ED before and during treatment with this medication. Bozkurt M, Gocmez C, Soylemez H, Daggulli M, Em S, Yildiz M, Atar M, Bozkurt Y, and Ozbey I. Association between neuropathic pain, pregabalin treatment, and erectile dysfunction. J Sex Med 2014;11:1816–1822.
تدمد: 1743-6095
DOI: 10.1111/jsm.12458
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1e258931c38c52d12fcacaab47ab52f3
https://doi.org/10.1111/jsm.12458
Rights: CLOSED
رقم الانضمام: edsair.doi.dedup.....1e258931c38c52d12fcacaab47ab52f3
قاعدة البيانات: OpenAIRE
الوصف
تدمد:17436095
DOI:10.1111/jsm.12458